Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis

Stephen L. Leib, Young S. Km, Stephen M. Black, Jay H. Tureen, Martin G. Täuber

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Abstract

This study explored the role of inducible nitric oxide (NO) synthase (iNOS) in an infant rat model of group B streptococcal meningitis. Brain iNOS activity increased during meningitis (P < .001), and iNOS was detected by immunocytochemistry in the walls of meningeal vessels and cells of the cerebrospinal fluid (CSF) inflammation. Animals treated with iNOS inhibitor aminoguanidine (AG; 130 mg/kg every 8 h) had reduced NO production (P < .05), higher CSF bacterial titers (P < .05), and increased incidence of seizures (P < .01) compared with untreated infected animals. AG also increased areas of severe hypoperfusion in the cortex (31% ± 14% in controls vs. 56% ± 16% in AG; P < .01) and the extent of cortical neuronal injury, both when administered at the time of infection (P < .05) and in established meningitis (P < .02). Thus, NO produced by iNOS may be beneficial in this model of experimental meningitis by reducing cerebral ischemia.

Original languageEnglish (US)
Pages (from-to)692-700
Number of pages9
JournalJournal of Infectious Diseases
Volume177
Issue number3
DOIs
StatePublished - Jan 1 1998

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis'. Together they form a unique fingerprint.

Cite this